1. Home
  2. ZBH

ZBH

Zimmer Biomet Holdings Inc.

Logo Zimmer Biomet Holdings Inc.

Health Care

Industrial Specialties

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Founded: 1927 Country:
United States
United States
Employees: N/A City: WARSAW
Market Cap: 24.9B IPO Year: N/A
Target Price: $141.00 AVG Volume (30 days): 1.4M
Analyst Decision: Buy Number of Analysts: 17
Dividend Yield: 0.80% Dividend Payout Frequency: Quarterly
EPS: 4.88 EPS Growth: 343.64
52 Week Low/High: $102.00 - $149.25 Next Earning Date: 05-02-2024
Revenue: $7,394,200,000 Revenue Growth: 6.55%
Revenue Growth (this year): 5.92% Revenue Growth (next year): 4.71%

Share on Social Networks:

Stock Insider Trading Activity of Zimmer Biomet Holdings Inc. (ZBH)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Jafry Syed A. ZBH Director Nov 9 '23 Buy $104.75 2,135 $223,641.25 4,060 SEC Form 4